Patents by Inventor Aurelija Zvirbliene

Aurelija Zvirbliene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies that bind thermophilic DNA polymerases
    Patent number: 10273530
    Abstract: This disclosure relates to antibodies that bind thermophilic family B DNA polymerases. Related uses, methods, and compositions are also provided.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: April 30, 2019
    Assignee: Thermo Fisher Scientific Baltics UAB
    Inventors: Renata Rimseliene, Donata Ulcinaite, Birute Gagiliene, Rasa Sukackaite, Aurelija Zvirbliene, Indre Kucinskaite-Kodze, Dovile Dekaminaviciute
  • ANTIBODIES THAT BIND THERMOPHILIC DNA POLYMERASES
    Publication number: 20170204454
    Abstract: This disclosure relates to antibodies that bind thermophilic family B DNA polymerases. Related uses, methods, and compositions are also provided.
    Type: Application
    Filed: January 13, 2017
    Publication date: July 20, 2017
    Applicant: Thermo Fisher Scientific Baltics UAB
    Inventors: Renata Rimseliene, Donata Ulcinaite, Birute Gagiliene, Rasa Sukackaite, Aurelija Zvirbliene, Indre Kucinskaite-Kodze, Dovile Dekaminaviciute
  • Process for the production of monoclonal antibodies
    Patent number: 7919314
    Abstract: Provided is a use of a recombinant chimaeric protein as an immunogen in a process for producing a monoclonal antibody, wherein the recombinant chimaeric protein is assembled into a virus-like particles, and includes a foreign protein or peptide or a fragment thereof.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: April 5, 2011
    Assignee: Biotechnologijos Institutas
    Inventors: Aurelija Zvirbliene, Alma Gedvilaite, Rainer Ulrich, Kestutis Sasnauskas
  • Process for the production of monoclonal antibodies
    Publication number: 20090269371
    Abstract: Provided is a use of a recombinant chimaeric protein as an immunogen in a process for producing a monoclonal antibody, wherein the recombinant chimaeric protein is assembled into a virus-like particles, and includes a foreign protein or peptide or a fragment thereof.
    Type: Application
    Filed: October 12, 2007
    Publication date: October 29, 2009
    Inventors: Aurelija Zvirbliene, Alma Gedvilaite, Rainer Ulrich, Kestutis Sasnauskas